PTEN and melanoma: Although data on melanoma risk in CS is limited, there is reported increased melanoma standardized incidence risk (SIR) of 8.5 in PTEN mutation positive CS patients (61), with median age of diagnosis of 40 years, compared with 63 years in the general population (71).